PATENT CLAIM ANALYSIS

Application Number: 15775147
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["548", "338100"]

Abstract:
A problem to be solved by the present invention is to provide a method for ameliorating pollakiuria and nocturia, in particular, nocturia caused by nocturnal polyuria by finding a composition that enhances the antidiuretic action of vasopressin or a vasopressin V2 receptor agonist. As a result of the studies, it has been found that imidafenacin enhances the antidiuretic action of vasopressin or the vasopressin V2 receptor agonist, whereby the present invention has been completed. According to the present invention, a composition containing imidafenacin can enhance the antidiuretic action of vasopressin or the vasopressin V2 receptor agonist, making it possible to ameliorate pollakiuria and nocturia, in particular, nocturia caused by nocturnal polyuria.

Claim (Index 4):
An antidiuretic composition comprising imidafenacin, wherein the antidiuretic composition is used with vasopressin or a vasopressin V2 receptor agonist.

Metadata:
- Claim Count in Document: 6.0
- Percentile: 93.0
- Lexical Diversity: 2.25926
- Patent Class: 548.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15811384', '14338554', '15528224', '12469801', '14338567']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6738142415897895
- 35 USC 102 Novelty (BERT): 0.5154458909656892
- Combined Prediction Score: 0.6579774065273795
- Mean Citation Score: 243.176278
- Max Citation Score: 268.35468
- Similarity Product: 175.70858290377618

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test